Independent and not affiliated with the FDA, MHRA, ISPE, PDA, or any agency. Get the appgoutham@madhadi.com
madhadi.comData Integrity & GxP Quality
Browse all topics → Articles Templates & Procedures Learning paths GlossaryScenariosToolsRegulatory ReferencesLearning PathsTopics About Start here
Log Plug-and-play starting point Clinical & GCP

Log: DSMB Unblinded Data Access Register

A plug-and-play access log naming everyone with legitimate access to unblinded interim trial data, grant/revoke dates, and the review that confirms no blinded study-team member is on the list, with a filled sample row and the regulations it satisfies.

Document type: Log

Read and copy the template below into your own quality system. It is a generic starting point for your own internal use, provided as is, with no warranty; see the Terms and License. Adopting it does not by itself create compliance.

This is a ready-to-use log for tracking who has legitimate access to unblinded interim trial data across the life of a study, so the firewall between the DSMB’s unblinded world and the sponsor’s blinded study team can be demonstrated, not just asserted. Replace every <<FILL: ...>> placeholder with your own specifics, set your document number, and route it through your normal document control. A filled sample row follows. Verify each cited regulation against the current source before you rely on it.

Purpose

The log answers one question an inspector or auditor will ask directly: “give me the list of everyone who could see unblinded data on this trial, and show me none of them are on the blinded study team.” A DSMB charter and meeting minutes describe the process; this log is the running roster that proves the process held at every point in time, not just at the moments someone happened to check.

Field table

FieldFormatRequiredWho completesWhen
Study / protocol numberTextYesLog administratorAt log opening
Individual name and roleTextYesLog administratorOn access grant
OrganizationTextYesLog administratorOn access grant
Basis for accessDSMB member / independent unblinded statistician / statistical data analysis center / unblinded safety desk / other (state)YesLog administratorOn access grant
Systems / data grantedText, naming the specific unblinded environment, dataset, or reportYesLog administratorOn access grant
Grant dateDateYesLog administratorOn access grant
Confirmed not a blinded study-team memberYes / No, with cross-check evidence referenceYesClinical QA or independent reviewerOn access grant and at each periodic review
Revoke dateDate, or “active”YesLog administratorOn access removal
Reason for revokeText (role ended, study closed, reassigned)ConditionalLog administratorOn access removal
Periodic review date and reviewerDate, nameYesClinical QAAt each defined review interval

Instructions

  1. Open the log at DSMB charter approval, before the first interim look, and add every individual granted unblinded access at that time.
  2. Add a new row the moment a new individual is granted access; do not batch entries after the fact.
  3. Before adding anyone, cross-check the name against the current sponsor blinded study-team roster and record the confirmation. A name appearing on both lists is a firewall breach, not a data entry error, and must be escalated the same day.
  4. Record a revoke date the day access actually ends, not the day the paperwork catches up.
  5. At each periodic review (recommended: at every interim look and at least annually for long-running trials), re-confirm every active entry against the current blinded-team roster and sign the review.
  6. Retain the log per the records retention schedule, for not less than <<FILL: retention period>>, alongside the DSMB charter and meeting records.

Retention

<<FILL: retention period and location, e.g. retained in the study's DSMB independent record, not the sponsor's blinded trial master file, for the life of the trial plus the applicable regulatory retention period>>.

Filled sample row

The following shows one completed entry, so you can see the level of detail expected. Details are illustrative.

FieldEntry
Study / protocol numberCVOT-2026-014
Individual name and roleProf. T. Andersson, independent unblinded statistician
OrganizationIndependent Statistical Data Analysis Center, <<FILL>>
Basis for accessIndependent unblinded statistician
Systems / data grantedUnblinded interim analysis environment, treatment-assignment dataset
Grant date02 March 2026
Confirmed not a blinded study-team memberYes; cross-checked against sponsor blinded roster BR-2026-014 v3, confirmed by M. Alvarez, 02 March 2026
Revoke dateActive
Reason for revokeN/A
Periodic review date and reviewer12 August 2026, M. Alvarez (confirmed still not on blinded roster)

Common inspection findings this log prevents

  • No documented list of who actually had unblinded access, so the sponsor can only assert the firewall held rather than demonstrate it.
  • An individual’s access recorded but never cross-checked against the blinded study-team roster.
  • Access still marked active for someone who left the unblinded role months earlier.
  • Periodic reviews that do not exist, so a roster drift (a blinded team member added to a shared system by mistake) goes undetected for the life of the trial.

How to adapt this log

  1. Set your document number and retention period in the header fields.
  2. If your program uses a standing DSMB across multiple studies, add a study/protocol column exactly as shown so one log can serve the whole program without losing per-study traceability.
  3. Point the cross-check step at your actual blinded-team roster source, whether that is an HR system, a delegation log, or a study team list maintained by clinical operations.
  4. Set your periodic review interval to match the interim analysis schedule in the DSMB charter.
Use madhadi.com as an app Full screen, works offline, one tap from your home screen.